| Sr. No. | Intermediate Name | CAS No. | Used in API Product |
|---|---|---|---|
| 1 | (R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid (RCMH) | 181289-33-8 | Pregabalin |
| 2 | 1-(3-Chlorphenyl)piperazine | 6640-24-0 | Trazodone HCL |
| 3 | 1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride | 52605-52-4 | Trazodone HCL |
| 4 | 4,7-Dichloroquinoline | 86-98-6 | Hydroxy Chloroquine Sulphate |
| 5 | 6-Bromo-3-hydroxypyrazine-2-carboxamide | 259793-88-9 | Favipiravir |
| 6 | 2-Butyl-4-chloro-5-formylimidazole (BCFI) | 83857-96-9 | Losartan |
| 7 | Methyl 2-methoxy-5-sulfamoyl benzoate | 33045-52-2 | Levosulpiride |
| 8 | o-Methoxy benzoic acid | 579-75-9 | Levosulpiride |
| 9 | p-Methoxy benzoic acid | 100-09-4 | Anti inflammatory drugs |
| 10 | N-(5-amino-2-methylphenl)-4-(3pyridyl)-2-pyrimidine-amine | 152460-10-1 | Imatinib Mesylate |
| 11 | N-(2-methyl-5-nitrophenyl)-4-(pyridine-3-yl)pyrimidine-2-amine | 152460-09-8 | Imatinib Mesylate |
| 12 | (2-Methyl-5-nitrophenyl) guanidine nitrate | 152460-08-7 | Imatinib Mesylate |
| 13 | 3-(Dimethylamino)-1-(pyridine-3yl)prop-2-en-1-one | 55314-16-4 | Nilotinib |
| 14 | Thio salicylic acid | 147-93-3 | Thimerosal |
| 15 | 7-Hydroxy-3,4-dihydroquinolin-2(1H)-one | 22246-18-0 | Aripiprazole |
| 16 | 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one | 54197-66-9 | Cilostazol |
| 17 | Bromo OTBN | 114772-54-2 | Valsartan |
| 18 | 2, 6-Dimethyl-5-Methoxycarbonyl-4-(3-Nitrophenyl)-1, 4- Dihydropyridine-3-Carboxylic Acid | 3259-03-8 | Lercanidipine & Benidipine |
| 19 | Endo-9-Methyl-9-aza-Bcclo3.3.1 Nonan-3-Amine | 76272-56-5 | Granisetron |
| 20 | 1 Methyl Indazole 3 Carboxylic acid | 50890-83-0 | Granisetron |
Working with one of the fastest growing pharmaceutical molecules (API & Intermediates) manufacturer brings with it a tremendous opportunity to create a lasting impact on global health. It is a chance to work alongside some brightest minds in science, management, and marketing sectors. Reine, with a talented team, can make chemistry & healthcare – pure, affordable, and accessible. By this, we can make possibilities endless.